Richter's Transformation clinical trials at UC Health

• A Study of ARQ 531 in Patients With Selected Hematologic Malignancies

  open to eligible people ages 18 years and up

  This is an open-label, multi-center Phase 1/2 study of ARQ 531 in patients with selected hematologic malignancies.

  at UCLA

Last updated: May 18, 2020